Featured Research

from universities, journals, and other organizations

Exhaled Nitric Oxide Monitoring Does Not Improve On Guidelines-based Asthma Management, Study Finds

Date:
September 24, 2008
Source:
National Jewish Medical and Research Center
Summary:
New research indicates that adolescent and young adult patients whose asthma is managed according to the latest NIH guidelines do not benefit from the addition of nitric-oxide monitoring. Nitric oxide is a biomarker for inflammation in the lungs.

Exhaled nitric oxide serves as a biomarker of inflammation in the lungs, and proponents have suggested that monitoring nitric oxide levels could help improve management of asthma. However, new research, which will be published in the Sept. 20 issue of The Lancet, indicates that adolescent and young adult patients whose asthma is managed according to the latest NIH guidelines do not benefit from the addition of nitric-oxide monitoring.

Related Articles


“While nitric-oxide monitoring did not improve asthma management, the good news is that most patients can bring their asthma under control by following NIH guidelines which are based on relatively easy-to-measure symptoms and lung function,” said Stanley Szefler , MD, lead author of the study and Head of Pediatric Clinical Pharmacology at National Jewish Health.

Asthma is a complex respiratory disorder in which airway inflammation and “twitchy” muscles surrounding the airways can make breathing difficult. Anti-inflammatory corticosteroids are the most effective controller medication for asthma. Nitric oxide is a biomarker of inflammation in the lungs. The researchers hypothesized that monitoring of nitric oxide might help detect patients with ongoing inflammation who needed additional medications to achieve full asthma control.

The researchers, from ten institutions in the National Institute of Allergy and Infectious Disease Inner City Asthma Consortium, evaluated two treatment regimens for 546 patients ages 12 -20 with persistent asthma. The patients all came from inner city neighborhoods with at least 20 percent of the population living below the federal poverty level.

All patients completed a three-week run-in period on a standard asthma treatment regimen based upon previous treatment, adherence to medications and asthma control. They were then randomized to either treatment based on NIH Guidelines for the Diagnosis and Management of Asthma or the guidelines plus nitric-oxide monitoring. The NIH guidelines recommended treatment levels based upon measures of days with symptoms in the preceding two weeks and lung-function testing. Nitric-oxide monitoring incorporated those guidelines but physicians could increase medications more than the guidelines called for if NO levels were high. Patients visited physicians every six to eight weeks at which time they were evaluated and treatment adjusted. The trial lasted 46 weeks.

The most significant improvements in asthma symptoms and levels of exhaled nitric oxide occurred during the three-week run in period. At enrollment 77 percent of patients did not have good control of their asthma. By the end of the run-in period 70 percent did have good control of their asthma. Those levels remained similar, ranging between 71 percent and 78 percent with good asthma control throughout the treatment period for all patients.

During the trial the mean number of days with asthma symptoms and pulmonary function were similar in the two groups. Admissions to the hospital, unscheduled use of healthcare, or asthma exacerbations also did not differ between groups. The nitric-oxide monitoring patients did have fewer bursts of oral steroids, a weeklong treatment for more severe asthma symptoms.

Although nitric-oxide monitoring did not make a difference in asthma management overall, post hoc analysis suggested that some subgroups may benefit from nitric-oxide monitoring. Obese patients and highly allergic patients had better control with nitric-oxide monitoring.

“Although nitric-oxide monitoring did not improve overall asthma management, we believe it may still be a useful tool for subsets of patients and in specific circumstances, such as asthma diagnosis, measuring response to inhaled corticosteroid therapy, assessing adherence to corticosteroid therapy, and the safe reduction of inhaled corticosteroid therapy,” said Dr. Szefler.


Story Source:

The above story is based on materials provided by National Jewish Medical and Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical and Research Center. "Exhaled Nitric Oxide Monitoring Does Not Improve On Guidelines-based Asthma Management, Study Finds." ScienceDaily. ScienceDaily, 24 September 2008. <www.sciencedaily.com/releases/2008/09/080918192830.htm>.
National Jewish Medical and Research Center. (2008, September 24). Exhaled Nitric Oxide Monitoring Does Not Improve On Guidelines-based Asthma Management, Study Finds. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/09/080918192830.htm
National Jewish Medical and Research Center. "Exhaled Nitric Oxide Monitoring Does Not Improve On Guidelines-based Asthma Management, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2008/09/080918192830.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins